Kirkland & Ellis LLP

Marc Sernel concentrates his practice on patent and other technology-related litigation with a particular focus on chemical, biotechnology, and computer science-related matters. Representative of Marc’s experience in the biotech area are patent matters involving DNA microarrays, intracellular transcription factors, and transgenic plant technology. Praised in the Legal 500 for his “excellent legal instincts,” Marc has acted as lead counsel and handled all aspects of trial work in district courts and at the International Trade Commission, and has successfully argued at the Federal Circuit.